UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)

Leukemia, 2022-05, Vol.36 (5), p.1215-1226

2022

Link zum Volltext

Verfügbarkeit prüfen

Quantitative Analysis of Cenobamate and Concomitant Anti-Seizure Medications in Human Plasma via Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry

Molecules (Basel, Switzerland), 2024-02, Vol.29 (4), p.884

2024

Link zum Volltext

Verfügbarkeit prüfen

Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)

Leukemia, 2022-05, Vol.36 (5), p.1450-1450

2022

Link zum Volltext

Verfügbarkeit prüfen

Cardiotoxicity of Targeted Cancer Drugs: Concerns, “The Cart Before the Horse,” and Lessons from Trastuzumab

Current cardiology reports, 2019-05, Vol.21 (5), p.33-33, Article 33

2019

Link zum Volltext

Verfügbarkeit prüfen

Development and Validation of a UHPLC–MS/MS-Based Method to Quantify Cenobamate in Human Plasma Samples

Molecules (Basel, Switzerland), 2022-10, Vol.27 (21), p.7325

2022

Link zum Volltext

Verfügbarkeit prüfen

Anthracycline Degradation in Cardiomyocytes: A Journey to Oxidative Survival

Chemical research in toxicology, 2010-01, Vol.23 (1), p.6-10

2010

Link zum Volltext

Verfügbarkeit prüfen

In ®Entresto we trust

Cardio-oncology (London, England), 2020-11, Vol.6 (1), p.25-25, Article 25

2020

Link zum Volltext

Verfügbarkeit prüfen

Primary Prevention Strategies for Anthracycline Cardiotoxicity: A Brief Overview

Chemotherapy (Basel), 2017-01, Vol.62 (3), p.159-168

2017

Link zum Volltext

Verfügbarkeit prüfen

Early Diastolic Dysfunction after Cancer Chemotherapy: Primary Endpoint Results of a Multicenter Cardio-Oncology Study

Chemotherapy (Basel), 2018-01, Vol.63 (2), p.55-63

2018

Link zum Volltext

Verfügbarkeit prüfen

Posaconazole and midostaurin in patients with FLT3-mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life study

Clinical and translational science, 2023-10, Vol.16 (10), p.1876-1885

2023

Link zum Volltext

Verfügbarkeit prüfen

An introduction to the metabolic determinants of anthracycline cardiotoxicity

Cardiovascular toxicology, 2007-06, Vol.7 (2), p.80-85

2007

Link zum Volltext

Verfügbarkeit prüfen

Cardiotoxicity of Antitumor Drugs

Chemical research in toxicology, 2008-05, Vol.21 (5), p.978-989

2008

Link zum Volltext

Verfügbarkeit prüfen

Rethinking Drugs from Chemistry to Therapeutic Opportunities: Pixantrone beyond Anthracyclines

Chemical research in toxicology, 2016-08, Vol.29 (8), p.1270-1278

2016

Link zum Volltext

Verfügbarkeit prüfen

The Reality of Pixantrone in Real Life

Acta haematologica, 2021-05, Vol.144 (3), p.244-245

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of low dose ponatinib in a case of Ph‐positive acute lymphoblastic leukaemia

British journal of haematology, 2019-10, Vol.187 (1), p.e15-e17

2019

Link zum Volltext

Verfügbarkeit prüfen

Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life

Chemotherapy (Basel), 2021-06, Vol.66 (1-2), p.47-52

2021

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel and Docetaxel Enhance the Metabolism of Doxorubicin to Toxic Species in Human Myocardium

Clinical cancer research, 2001-06, Vol.7 (6), p.1511-1515

2001

Link zum Volltext

Verfügbarkeit prüfen

The concomitant management of cancer therapy and cardiac therapy

Biochimica et biophysica acta. Biomembranes, 2015-10, Vol.1848 (10), p.2727-2737

2015

Link zum Volltext

Verfügbarkeit prüfen

From Cardiac Anthracycline Accumulation to Real-Life Risk for Early Diastolic Dysfunction

JACC CardioOncology, 2022-03, Vol.4 (1), p.139-140

2022

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Cardiotoxicity of Targeted Cancer Drugs: Concerns, “The Cart Before the Horse,” and Lessons from Trastuzumab

Current cardiology reports, 2019-04, Vol.21 (5), p.40-40, Article 40

2019

Link zum Volltext

Verfügbarkeit prüfen

From Cardiac Anthracycline Accumulation to Real-Life Risk for Early Diastolic Dysfunction: A Translational Approach

JACC CardioOncology, 2022-03, Vol.4 (1), p.139-140

2022

Link zum Volltext

Verfügbarkeit prüfen

N°94 – Reduction of EEG connectivity induced by cenobamate correlates with clinical and cognitive outcomes

Clinical neurophysiology, 2023-06, Vol.150, p.e101-e101

2023

Link zum Volltext

Verfügbarkeit prüfen

Do You Know Pixantrone?

Chemotherapy (Basel), 2017-01, Vol.62 (3), p.192-193

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)

Publikationsform

Sprache

Englisch
(50)
Japanisch
(4)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Quantitative Analysis of Cenobamate and Concomitant Anti-Seizure Medications in Human Plasma via Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry

Cardiotoxicity of Targeted Cancer Drugs: Concerns, “The Cart Before the Horse,” and Lessons from Trastuzumab

Development and Validation of a UHPLC–MS/MS-Based Method to Quantify Cenobamate in Human Plasma Samples

Anthracycline Degradation in Cardiomyocytes: A Journey to Oxidative Survival

In ®Entresto we trust

Primary Prevention Strategies for Anthracycline Cardiotoxicity: A Brief Overview

Early Diastolic Dysfunction after Cancer Chemotherapy: Primary Endpoint Results of a Multicenter Cardio-Oncology Study

Posaconazole and midostaurin in patients with FLT3-mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life study

P487: MIDOSTAURIN PLASMA EXPOSURE IN PATIENTS WITH FLT3‐MUT ACUTE MYELOID LEUKEMIA UNDERGOING POSACONAZOLE PROPHYLAXIS DURING INDUCTION TREATMENT: A PROSPECTIVE MULTICENTRE STUDY FROM THE SEIFEM GROUP

High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study

An introduction to the metabolic determinants of anthracycline cardiotoxicity

Cardiotoxicity of Antitumor Drugs

Rethinking Drugs from Chemistry to Therapeutic Opportunities: Pixantrone beyond Anthracyclines

The Reality of Pixantrone in Real Life

Efficacy and safety of low dose ponatinib in a case of Ph‐positive acute lymphoblastic leukaemia

Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life

Paclitaxel and Docetaxel Enhance the Metabolism of Doxorubicin to Toxic Species in Human Myocardium

The concomitant management of cancer therapy and cardiac therapy

From Cardiac Anthracycline Accumulation to Real-Life Risk for Early Diastolic Dysfunction

Correction to: Cardiotoxicity of Targeted Cancer Drugs: Concerns, “The Cart Before the Horse,” and Lessons from Trastuzumab

From Cardiac Anthracycline Accumulation to Real-Life Risk for Early Diastolic Dysfunction: A Translational Approach

N°94 – Reduction of EEG connectivity induced by cenobamate correlates with clinical and cognitive outcomes

Do You Know Pixantrone?

Aktive Filter

Suchergebnisse filtern